A redundant oncogenic potential of the retinoic receptor (RAR) α, β and γ isoforms in acute promyelocytic leukemia

被引：25
|
作者：
Marinelli, A. [1 ]
Bossi, D. [1 ]
Pelicci, P. G. [1 ]
Minucci, S. [1 ]
机构：
[1] European Inst Oncol, Dept Expt Oncol, I-20100 Milan, Italy
来源：
LEUKEMIA | 2007年 / 21卷 / 04期
关键词：
acute myeloid leukemias; acute promyelocytic leukemia; PML-RAR; retinoic acid;
D O I：
10.1038/sj.leu.2404572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Alterations of the retinoic acid receptor (RAR) a locus are found in 100% of acute promyelocytic leukemia patients, where chromosomal translocations generate the promyelocytic leukemia (PML)-RAR alpha chimeric protein. Here, we have investigated the biological properties of the other RAR isoforms (RAR beta and RAR gamma), through the generation and characterization of artificial PML-RAR'x' fusion proteins. Surprisingly, we found that all of the RAR isoforms share an identical oncogenic potential in vitro, thus implying that the selection of the RAR alpha locus in leukemia patients must occur - rather than through functional differences among the various RAR isoforms - as the consequence of the nuclear architecture of the different RAR loci.
引用
收藏
页码：647 / 650
页数：4
相关论文
共 50 条
  • [1] A redundant oncogenic potential of the retinoic receptor (RAR) α, β and γ isoforms in acute promyelocytic leukemia
    A Marinelli
    D Bossi
    P G Pelicci
    S Minucci
    Leukemia, 2007, 21 : 647 - 650
  • [2] Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML/RARα in acute promyelocytic leukemia
    Shao, Xue-jing
    Wang, Wei
    Xu, Ai-xiao
    Qi, Xiao-tian
    Cai, Min-yi
    Du, Wen-xin
    Cao, Ji
    He, Qiao-jun
    Ying, Mei-dan
    Yang, Bo
    ACTA PHARMACOLOGICA SINICA, 2025, 46 (02) : 462 - 473
  • [3] Infantile acute promyelocytic leukemia without an RARα rearrangement
    Hori, Tsukasa
    Suzuki, Nobuhiro
    Hatakeyama, Naoki
    Yamamoto, Masaki
    Inazawa, Natsuko
    Miyachi, Hayato
    Taki, Tomohiko
    Tsutsumi, Hiroyuki
    PEDIATRICS INTERNATIONAL, 2011, 53 (06) : 1070 - 1073
  • [4] Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
    Shao, Xuejing
    Chen, Yingqian
    Wang, Wei
    Du, Wenxin
    Zhang, Xingya
    Cai, Minyi
    Bing, Shaowei
    Cao, Ji
    Xu, Xiaojun
    Yang, Bo
    He, Qiaojun
    Ying, Meidan
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (04) : 1856 - 1870
  • [5] Translocations of the RARα gene in acute promyelocytic leukemia
    Zelent, A
    Guidez, F
    Melnick, A
    Waxman, S
    Licht, JD
    ONCOGENE, 2001, 20 (49) : 7186 - 7203
  • [6] Translocations of the RARα gene in acute promyelocytic leukemia
    Arthur Zelent
    Fabien Guidez
    Ari Melnick
    Samuel Waxman
    Jonathan D Licht
    Oncogene, 2001, 20 : 7186 - 7203
  • [7] Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure
    R E Gallagher
    E L Schachter-Tokarz
    D-C Zhou
    W Ding
    S H Kim
    B J Sankoorikal
    W Bi
    K J Livak
    J L Slack
    C L Willman
    Leukemia, 2006, 20 : 556 - 562
  • [8] Monitoring PML-RARα in acute promyelocytic leukemia
    Joseph G. Jurcic
    Current Oncology Reports, 2003, 5 (5) : 391 - 398
  • [9] Retinoic acid receptor α (RARα) mutations in human leukemia
    Parrado, A
    Chomienne, C
    Padua, RA
    LEUKEMIA & LYMPHOMA, 2000, 39 (3-4) : 271 - 282
  • [10] Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion
    Okazuka, Kiyoshi
    Masuko, Masayoshi
    Seki, Yoshinobu
    Hama, Hitomi
    Honma, Noriyuki
    Furukawa, Tatsuo
    Toba, Ken
    Kishi, Kenji
    Aizawa, Yoshifusa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (03) : 246 - 249
12345